Behr-Gross M-E
CS 30026, Direction Européenne de la Qualité du Médicament et Soins de Santé, Conseil de l'Europe, 67081 Strasbourg, France.
Transfus Clin Biol. 2009 May;16(2):237-40. doi: 10.1016/j.tracli.2009.04.002. Epub 2009 May 13.
In the context of increased demand of blood components, it is highly desirable to ensure development and implementation of established standards for ethical, organisational and regulatory fields in order to guarantee the sufficiency, quality and safety of blood components and their derivatives as well as the protection of donors and recipients. In Europe, the contributions of the European public institutions is fundamental for the achievement of these goals and for the harmonisation of practices inherent to transfusional medicine activities. The Council of Europe with its 47 member states constitutes the ideal platform to tackle these themes: for half a century, its public health and bioethics experts have contributed to the elaboration of conventions and recommendations which serve as a model to elaboration of national or European regulations relevant to this field.
在血液成分需求增加的背景下，非常有必要确保制定和实施伦理、组织和监管领域的既定标准，以保证血液成分及其衍生物的充足性、质量和安全性，以及对献血者和受血者的保护。在欧洲，欧洲公共机构的贡献对于实现这些目标以及协调输血医学活动固有的做法至关重要。拥有47个成员国的欧洲委员会构成了解决这些主题的理想平台：半个世纪以来，其公共卫生和生物伦理专家为制定公约和建议做出了贡献，这些公约和建议为制定该领域相关的国家或欧洲法规提供了典范。
